Exagen Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.65

-0.10 (-2.11%)

As of Jun 30, 10:31 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +995.1% upside

Low Target $37.48

Average Target $50.92

High Target $70.07

Current Price $4.65

Current
$4.65

Target
$50.92

$37.48 $50.92 avg $70.07

Scenario Analysis

Bear Case

$37.48

706.0%

Low target

Base Case

$50.92

+995.1%

Avg target

Bull Case

$70.07

+1,406.9%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$12.23

-62.0% from high

52-Week Low

$2.59

+79.5% from low

Target vs 52W High

$50.92

+316.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%